CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960 | +90.5% | 64,404 | +39.9% | 0.00% | 0.0% |
| Q2 2023 | $504 | -74.8% | 46,023 | +7780.7% | 0.00% | – |
| Q2 2022 | $2,000 | -97.8% | 584 | -98.0% | 0.00% | – |
| Q1 2022 | $92,000 | -8.0% | 29,580 | 0.0% | 0.00% | – |
| Q4 2021 | $100,000 | -7.4% | 29,580 | -0.4% | 0.00% | – |
| Q3 2021 | $108,000 | -55.0% | 29,701 | -46.0% | 0.00% | – |
| Q2 2021 | $240,000 | -2.8% | 54,965 | +1.0% | 0.00% | – |
| Q1 2021 | $247,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
| Q4 2020 | $312,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
| Q3 2020 | $394,000 | +107.4% | 54,400 | 0.0% | 0.00% | – |
| Q2 2020 | $190,000 | +134.6% | 54,400 | 0.0% | 0.00% | – |
| Q1 2020 | $81,000 | -24.3% | 54,400 | 0.0% | 0.00% | – |
| Q4 2019 | $107,000 | -61.6% | 54,400 | 0.0% | 0.00% | – |
| Q3 2019 | $279,000 | -44.8% | 54,400 | -22.8% | 0.00% | -100.0% |
| Q2 2019 | $505,000 | -30.0% | 70,500 | +29.8% | 0.00% | 0.0% |
| Q1 2019 | $721,000 | +68.9% | 54,300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $427,000 | -41.2% | 54,300 | -17.1% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | -17.4% | 65,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $879,000 | – | 65,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |